10-Dec-15 The Japan International Cooperation Agency (JICA) has provided Vietnam with USD104 mn to finance the construction of ten hospitals. Costing USD120 mn, they are also funded by ministry and local budgets. The projects have been implemented since 2012, and are expected to ease overload at central level hospitals, and improve surgery, emergency and intensive care services. [image: JICA]

09-Dec-15 Many countries in East Asia now have to worry about losing as much as 15% of their working-age population by 2040, according to the World Bank. It said aging population and low fertility rates are to blame. Policies such as encouraging women to work, reforming pension schemes and shifting focus from hospital care to primary care are being recommended. [image: Zhang Peng / LightRocket / Getty Images]

16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]

15-Oct-15 Japan's drug regulator, the Pharmaceuticals and Medical Devices Agency (PMDA), is set to open an India office soon. The move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan either through exports or by forging joint ventures with partners in that country. [image: The Economic Times]

15-Oct-15 Vetter, a global leader in aseptic manufacturing of drug-delivery systems, has announced a new business entity in Japan. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. [image: Business Wire]